|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-2-11
|
|
pubmed:abstractText |
Erythropoietin (EPO) has cytoprotective effects apart from its hematopoietic effects. We studied the effects of different EPO molecules on podocyte signaling in vitro and on podocyte survival in an experimental model of diabetic kidney injury (db/db mouse).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0143
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
411-5
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19096223-Animals,
pubmed-meshheading:19096223-Cells, Cultured,
pubmed-meshheading:19096223-Diabetes Complications,
pubmed-meshheading:19096223-Diabetes Mellitus, Experimental,
pubmed-meshheading:19096223-Erythropoietin,
pubmed-meshheading:19096223-Janus Kinases,
pubmed-meshheading:19096223-Mice,
pubmed-meshheading:19096223-Podocytes,
pubmed-meshheading:19096223-Polyethylene Glycols,
pubmed-meshheading:19096223-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:19096223-Recombinant Proteins,
pubmed-meshheading:19096223-Signal Transduction
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Erythropoietin prevents diabetes-induced podocyte damage.
|
|
pubmed:affiliation |
Department of Internal Medicine, Hannover Medical School, Hannover, Germany. schiffer.mario@mh-hannover.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
